Vor Biopharma's market cap is currently $244.13M. The company's EPS TTM is $-0.26; its P/E ratio is ―; Vor Biopharma is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
